Chronic overmedication: compounded drug waste and safety concerns

Polypharmacy is a cost and safety issue that can be addressed. The right technology platform can reduce risk by identifying risky treatment regimens, providing clinicians with specific “stop/switch/consolidation” opportunities, and tracking whether changes are sustained through replenishment and adherence patterns.

The post Chronic Overmedication: Polydrug Waste and Safety Concerns appeared first on MedCity News.